Dr. Reddy’s Laboratories (NYSE:RDY) has launched Doxercalciferol Injection, 4 mcg/2 mL (2 mcg/mL) Multiple-Dose Vials, the therapeutic generic equivalent of Sanofi-Aventis’ Hectorol (doxercalciferol) Injection 4 mcg/2 mL (2 mcg/mL) Multiple-Dose Vials.
The Hectorol Injection 4 mcg/2 mL (2 mcg/mL) had brand and generics U.S. sales of ~$138M for year ended September 2019, according to IQVIA Health.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.